Aldgamycin E is a neutral macrolide antibiotic that can be derived from culture filtrates of Streptomyces lavendulae. Aldgamycin E has antibacterial activity.
Especificaciones
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Tipo de acción
INHIBITOR
Nombres e identificadores
Peso molecular
742.85
Datos avanzados
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculadoras de soluciones
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Reseñas
Reseñas de cliente
Application Protocols
No vendor-tested bioassay protocols (WB, IHC, IF, FC, etc.) or dilutions are provided for this small-molecule product.
General usage examples for research workflows:
LC-MS reference: Prepare a 1–5 mM stock in anhydrous DMSO. Dilute to 0.5–5 µg/mL in 50:50 ACN/H2O + 0.1% formic acid for injection. Record retention time and MS/MS fragments to build a reference library.
Screening assays: Prepare 10 mM DMSO stock; perform serial dilutions to desired concentrations, maintaining final DMSO ≤0.5% v/v in assay buffer. Include vehicle controls.
Stability check: Incubate 10 µM solution in assay buffer at 25 °C and 37 °C; sample at 0, 2, 6, 24 h; analyze by LC to confirm integrity.
These are illustrative, literature-style procedures; adjust to your assay format. Always confirm solubility and stability experimentally.
Biological Roles
Literature/general biological context (no clinical claims):
Macrolide class mechanism: Many macrolides bind to the nascent peptide exit tunnel of the bacterial 50S ribosomal subunit, modulating peptide elongation. Binding involves hydrophobic contacts and H‑bonding mediated by macrolactone hydroxyls and sugar moieties.
Selectivity: Interactions are typically stronger with bacterial rRNA than with eukaryotic cytosolic ribosomes due to sequence/structure differences in the 23S rRNA domain V (literature consensus for macrolides). Specific binding constants for Aldgamycin E are not provided here.
Resistance considerations: Known bacterial resistance mechanisms to macrolides include ribosomal methylation (erm genes), efflux pumps, and target mutations. These mechanisms can be studied in vitro using Aldgamycin E as a probe compound.
Biogenesis: Aldgamycins are polyketide-derived natural products biosynthesized by modular PKSs in Streptomyces spp., followed by tailoring (glycosylation, oxidation, methylation). Such pathways are model systems in natural product enzymology.
Biophysical assays: In vitro binding can be profiled by ribosome toeprinting, fluorescence anisotropy (with labeled analogs), or surface plasmon resonance using reconstituted bacterial ribosomal subunits.
Note: Quantitative potency, MIC values, and cellular activity for Aldgamycin E are not specified for this item; consult primary literature or generate de novo data under your assay conditions.
Buffer Applications
This product is a hydrophobic small-molecule macrolide and is not a buffering reagent. It is not typically used to prepare buffer systems or control pH.
Practical notes:
For biological assays, dissolve in DMSO to make concentrated stocks and dilute into pre-made assay buffers (e.g., phosphate, HEPES, MOPS) while maintaining low final organic content.
If adsorption or precipitation occurs on dilution, include a minimal amount of co-solvent (e.g., 0.1–1% DMSO) and pre-wet plasticware. Validate solubility empirically.
Green Alternatives
Because Aldgamycin E is a complex, acid/base‑sensitive macrolide, solvent choice strongly influences stability and environmental footprint. Below is general guidance to reduce environmental impact while maintaining compound integrity (verify experimentally for this item):
Prefer greener polar aprotics: Where DMSO is standard for stock solutions, consider Cyrene (dihydrolevoglucosenone) or propylene carbonate for certain workups and extractions if stability permits. Note: Solubility/stability of macrolides in these solvents must be verified; DMSO remains the most reliable but is not the greenest.
Alcohols over chlorinated solvents: Use ethanol or isopropanol for short manipulations and crystallizations when feasible instead of dichloromethane or chloroform. Avoid base-catalyzed conditions in alcohols to minimize transesterification.
Aqueous-organic systems: For preparative chromatography, consider ethanol/water or ACN/water mobile phases (with volatile buffers) to reduce halogenated solvent use.
Energy minimization: Dissolve with mild warming (≤40 °C) and sonication rather than prolonged reflux; protect from light to avoid degradation and rework.
Balanced trade-offs (general):
DMSO: High solvency; moderate EHS profile; biodegradable but persistent odor and disposal considerations.
Ethanol/IPA: Renewable routes available; safer; may not achieve high concentrations.
Ethyl acetate: Greener than chlorinated solvents; limited for long-term solutions but good for extractions.
Action: Start with ethanol or ethyl acetate for non-critical steps; reserve DMSO for stock solutions and assays where solubility is limiting. Validate stability by LC before adopting greener substitutions.
Pharmaceutical Uses
No therapeutic or clinical use is claimed or supported for this catalog item. For research use only.
Relevant non-clinical pharmaceutical/CMC contexts (general for macrolide standards):
Reference standard: Can be used as an analytical reference for impurity profiling, stability-indicating methods, or identity testing in development programs involving macrolide scaffolds.
Process development studies: Serves as a probe substrate for reaction scouting (e.g., selective acylations, deprotections) to understand macrolide chemoselectivity under manufacturing-like conditions.
Formulation research: Useful for pre-formulation solubility screening (cosolvents, cyclodextrins, lipid-based systems) to understand behavior of related macrolide chemotypes; any results are for research only and not for human use.
Pharmacopeial status: Not specified for this item; refer to relevant pharmacopeias and the CoA if applicable.
Ensure all handling conforms to research-only constraints and institutional policies.
Physical Properties
Item-specific properties (Product Data):
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Literature/General expectations for macrolide natural products (for planning only; verify for Aldgamycin E via CoA/SDS):
Physical state: Typically an amorphous to microcrystalline solid; often forms foams or glasses on drying.
Melting behavior: Often decomposes or shows broad softening rather than a sharp MP (literature trend for complex macrolides).
Solubility: Frequently soluble in polar aprotic/organic solvents such as DMSO and DMF; variably soluble in MeOH, EtOH, acetonitrile, ethyl acetate; poor solubility in water. Final working stocks are commonly prepared at 1–10 mM in dry DMSO, then diluted into assay media.
Partitioning: High polarity-functional group count plus sizable hydrophobic ring often yields moderate to high logP with amphiphilic behavior; exact logP for Aldgamycin E is not established here.
UV-Vis: Conjugated enone/alkene chromophores in macrolides can show UV absorbance in the 200–280 nm region; exact maxima and extinction coefficients should be determined experimentally.
Stability: Macrolactones can be sensitive to strong acid/base (risk of transesterification or hydrolysis) and prolonged light/heat exposure.
Note: For exact BP/MP/density/n and any spectral reference data, consult the item’s CoA/Spec Sheet and SDS. Do not rely on generalized literature values for QC release.
Quality and Grades
Item-specific details:
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Guidance on quality expectations for complex natural product standards (general):
Identity confirmation: HRMS within acceptable ppm error, full 1H/13C NMR assignment (with 2D correlations), and chromatographic purity by HPLC/UPLC (often reported at 95%+ for screening libraries unless otherwise stated). For macrolides, optical rotation and, where possible, comparison to literature spectra are valuable.
Purity reporting: Percent-area by UV or ELSD at a defined wavelength/method should be specified on the CoA. Trace solvent/water content may be reported by Karl Fischer/GC; if not on CoA, request as needed for sensitive applications.
Stabilizers: Typically none for macrolides; if present (e.g., small % antioxidant or acid scavenger), this will be explicitly disclosed on the CoA. Do not assume any stabilizer if not stated.
Use-case alignment: For analytical reference and screening, low-UV-absorbing residuals and single-major-peak purity are emphasized. For semisynthesis, residual mineral acids/bases and water content are critical due to macrolactone sensitivity.
Action for this SKU (A1417022): Because grade/purity are not specified here, consult the lot-specific CoA/Spec Sheet for exact assay, chromatographic method, residual solvents, water content, and any stabilizers. Align acceptance criteria with your internal method and end-use.
Reaction and Applications
Research applications (non-clinical):
Analytical reference: Use Aldgamycin E as a reference standard for method development/validation in natural product profiling, dereplication, and metabolomics (LC-MS/MS, qNMR). Establish retention time, CID fragments, and UV signature.
Chemical biology: Probe macrolide–ribosome interactions or macrolide binding to bacterial 50S subunits in vitro (biophysical assays), benchmarking against other macrolides. No in vivo/clinical use.
SAR and semisynthesis: Serve as a starting point for derivatization of peripheral hydroxyls (acylation, carbamate formation) and selective modifications to modulate polarity and binding.
Biosynthetic studies: Use as a substrate/standard in polyketide synthase pathway investigations and isotope-labeling flux studies.
Practical tips (general for macrolides):
Protect from strong acid/base to avoid macrolactone cleavage or sugar hydrolysis. Acid-labile glycosidic bonds may require neutral conditions.
For acylation of hydroxyl groups: use mild acyl donors (e.g., acyl anhydrides) with DMAP in dry DCM/DMF at 0–25 °C; monitor by LC-MS. Regioselectivity can be improved using transient silyl protection (TBS, TBDPS) on more reactive alcohols.
Hydrogenation of isolated C=C: H2, Pd/C (5–10%), MeOH/EtOH at ambient temperature/pressure; monitor closely to avoid over-reduction.
Glycoside manipulations: If present, selective deprotection under neutral or buffered conditions is advised; avoid protic acids.
Always confirm structural integrity after any transformation by 2D NMR and HRMS.
Reaction Conditions
General, literature-informed conditions for typical macrolide manipulations (adjust empirically for Aldgamycin E; verify stability by LC-MS/NMR):
Mild acylation of alcohols: Ac2O (1.1–2.0 equiv), DMAP (5–10 mol%), pyridine or DCM as solvent; 0–25 °C, 0.5–4 h. Quench with MeOH and aqueous workup at neutral pH.
Carbamate formation: CDI (1.1–1.5 equiv) in dry DMF or THF, 0–25 °C, then amine addition; avoid excess heat. Alternatively, p‑nitrophenyl carbonate activation at 0–5 °C.
Silylation (protection): TBSCl (1.2–2.0 equiv), imidazole (2–3 equiv), DMF, 0–25 °C, 1–3 h. Desilylation: TBAF (1.0 equiv) in THF at 0–25 °C, minutes to hours.
Hydrogenation of isolated C=C: H2 (1 atm), 5–10% Pd/C (5–10 wt% relative to substrate), MeOH/EtOH, RT, 0.5–4 h. Monitor to prevent over-reduction.
Epoxidation: mCPBA (1.1 equiv) in DCM at 0–5 °C, 0.5–2 h; buffer with NaHCO3 to reduce epimerization.
Glycosidic manipulations: For deacetylation, use NaOMe (cat.) in MeOH at 0–5 °C, minutes, then neutralize acetic acid; avoid strong acid that may cleave glycosidic bonds.
Purification: Normal-phase silica with EtOAc/hexanes or DCM/MeOH gradients; for highly polar analogs, reverse-phase C18 with ACN/H2O + 0.1% formic acid or ammonium bicarbonate (volatile) is effective.
Yields: Highly substrate- and site-dependent; expect moderate yields (40–80%) for single-site transformations under carefully optimized, mild conditions.
Note: The above are literature-style guidelines for macrolides broadly and are not item-specific specifications.
Safety and Handling
Authoritative safety data must be taken from the SDS for this specific item.
Item-specific Product Data:
GHS classification: Not specified for this item; refer to SDS.
Signal word: Not specified for this item; refer to SDS.
Hazard (H) statements: Not specified for this item; refer to SDS.
Pictograms: Not specified for this item; refer to SDS.
Storage conditions: Store at −20°C.
Shipping: Shipped in ice chest with ice pads (cold chain maintained).
General safety considerations for macrolide small molecules (literature-level guidance; not a substitute for SDS):
Potential hazards: May cause irritation to skin/eyes/respiratory tract upon contact with powders or aerosols. Avoid inhalation and contact.
PPE: Lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Work in a certified fume hood when weighing/handling powders.
Handling: Use clean, dry tools; minimize freeze–thaw cycles. Prepare solutions with anhydrous solvents to limit hydrolysis of macro-lactone linkages.
Incompatibilities: Strong acids/bases (can promote hydrolysis/transesterification), strong oxidants, and prolonged exposure to UV/visible light and elevated temperatures.
Spill/First aid (overview): Avoid dust generation; contain with inert absorbent. On skin/eye contact, rinse with water for 15 minutes; seek medical attention as needed. If inhaled, move to fresh air.
Waste: Dispose according to institutional hazardous waste protocols for organic compounds; do not release to drains.
Always defer to and follow the SDS and institutional EHS guidance for hazard classification and first-aid measures.
Solvent Selection
Practical dissolution guidance (general for macrolide small molecules; verify with your preliminary solubility tests):
Primary stock solvents: DMSO (anhydrous) is typically the most reliable to prepare 1–10 mM stocks. DMF can be an alternative when DMSO is undesired.
Secondary solvents/co-solvents: Methanol or ethanol can dissolve many macrolides at moderate concentrations; acetonitrile sometimes works as a co-solvent in LC-MS buffers. Ethyl acetate and dichloromethane are useful for extractions but less so for long-term storage solutions.
Aqueous systems: Poor intrinsic aqueous solubility is common. For biological assays, dilute DMSO stocks into buffered media, maintaining final DMSO ≤0.1–1% v/v. Use surfactants (e.g., 0.01–0.05% Tween-80) only if compatible with the assay and after confirming stability.
Polarity: Amphiphilic; the macrocycle and sugar(s) provide H-bonding sites, while the hydrophobic backbone drives poor water solubility. Expect improved solubility in polar aprotic media.
Small comparison (general):
DMSO: Highest solvating power; compatible with most screening assays at low %; may complicate some enzyme assays.
MeOH/EtOH: Volatile; convenient for short-term manipulations and chromatography; potential for transesterification under basic conditions—avoid base.
ACN: Good for LC; moderate solvation; often requires co-solvent.
Tips:
Warm gently (≤40 °C) and sonicate to aid dissolution. Avoid prolonged heating or strong base.
Filter 0.2 µm PTFE if particulates persist; confirm no adsorption losses.
Storage and Reconstitution
Item-specific Product Data:
Storage conditions: Store at −20 °C.
Shipped in: Ice chest with ice pads.
Research use note: For research use only.
General handling and reconstitution guidance for macrolide small molecules:
Upon receipt: Allow the sealed container to equilibrate to room temperature before opening to prevent condensation. If supplied as a solid, gently centrifuge vial to collect material from the cap.
Aliquoting: If frequent use is anticipated, prepare small aliquots of stock solution (e.g., 5–20 mM in anhydrous DMSO) under dry, inert atmosphere (optional) to minimize freeze–thaw cycles.
Storage of solutions: Store DMSO stocks at −20 °C, protected from light. For long-term storage (>3 months), consider −80 °C. Avoid repeated freeze–thaw; thaw on ice and refreeze promptly.
Stability: Macrolactones may degrade under acidic/basic conditions and on prolonged exposure to light/heat. Confirm stability by periodic LC-MS or HPLC.
Solid-state storage: Keep tightly closed, desiccated, and protected from light. If hygroscopicity is observed, store with desiccant in a sealed secondary container.
Reconstitution solvent choice: Prefer anhydrous DMSO; if using alcohols or ACN, verify solubility and stability first. Filter sterilize only if necessary and compatible (0.2 µm PTFE); assess adsorption losses.
Always refer to the lot-specific CoA and SDS for any additional storage notes, thawing considerations, and shelf-life guidance.
Structure and Identity
Short description: Aldgamycin E is a complex macrolide-type small molecule natural product standard supplied for research use.
Item-specific identifiers (from Product Data):
CAS: 11011-06-6
InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Literature/General structural description (for context; verify against the specific CoA for this lot):
Chemical class: Macrolide (polyketide) natural product.
Core features: Large macrocyclic lactone (typically 14–16 membered in macrolides), multiple secondary/tertiary alcohols, conjugated enone/alkene motifs, and one or more deoxy-sugar appendages O‑glycosidically linked to the aglycone (features reported generically for aldgamycins/macrolides in literature).
Stereochemistry: Richly stereodefined polypropionate backbone with multiple chiral centers (macrolides commonly possess >10 stereocenters). Exact absolute configuration for Aldgamycin E should be confirmed from primary literature or the item’s CoA.
2D structure in words (literature-level): A large lactone ring bearing several hydroxyl substituents and double bonds; one edge of the ring carries a glycosidic linkage to a deoxy sugar; additional methyl substituents decorate the backbone in a pattern typical of polyketide biosynthesis.
Identity guidance:
For analytical confirmation, combine high-resolution MS, 1H/13C NMR with 2D (HSQC/HMBC/COSY), and optical rotation against literature for Aldgamycin E. Retention time in a validated LC-MS method should match an authenticated standard.
Synthetic Utility
Aldgamycin E, as a polyfunctional macrolide, offers multiple handles for selective derivatization and methodological development (general guidance; confirm structure-specific sites with your CoA/NMR):
Alcohol derivatization: Secondary/tertiary hydroxyls can be acylated (Ac2O, AcCl, or mixed anhydrides; DMAP catalysis) or converted to carbonates/carbamates (e.g., CDI or triphosgene alternatives) to modulate polarity and binding characteristics.
Protection strategies: Silyl protections (TBS, TBDPS) installed under mild conditions (imidazole/DMF) allow orthogonal masking; removal with HF•pyridine or TBAF at low temperature helps preserve the macrolactone.
Alkene manipulations: Selective hydrogenation (H2, Pd/C) or epoxidation (mCPBA at 0–5 °C) enables site-specific modifications. Epoxides can undergo regioselective opening to introduce heteroatoms.
Glycoside chemistry (if present): Temporary protection of sugar hydroxy groups (benzyl, silyl) enables aglycone editing; glycosyl donors/acceptors can be swapped to probe SAR.
C–H oxidation: Late-stage oxidations using mild catalysts (e.g., P450 mimics or photoredox) can introduce hydroxyls without cleaving the lactone, though selectivity is highly substrate-dependent.
Conjugation: Formation of biotinylated or fluorophore-tagged analogs via carbonate/carbamate linkers on peripheral OH groups supports target engagement studies.
Given the lability of macrolactones, reactions should be short, cold-to-ambient, and buffered away from strong acids/bases. Analytical LC-MS monitoring is essential.
Target Specificity
This SKU is a small-molecule macrolide standard, not an antibody or affinity reagent. Target specificity data such as antigen name, clone, isotype, or species reactivity do not apply.
General biological context (literature): Macrolides often interact with the bacterial 50S ribosomal subunit; however, binding constants and selectivity profiles for Aldgamycin E are not provided for this item. Generate target engagement data using your in vitro system if required.
Preguntas frecuentes
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 11011-06-6, the molecular formula is C37H58O15, and the molecular weight is 742.85 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Utilizamos cookies para garantizar el correcto funcionamiento del sitio web y, cuando esté permitido, para mejorar su experiencia. Puede gestionar sus preferencias en cualquier momento en Configuración. Más información en nuestra Política de Cookies.
¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?
Recordármelo más tarde
¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.